Expand TSHA Menu
TSHA MENU

TSHA Latest Press Releases

-- June 5, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:01 AM

-- May 6, 2026 --

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- May 1, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- April 29, 2026 --

Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 Globe Newswire 8:00 AM

-- April 27, 2026 --

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting Globe Newswire 5:21 PM

-- April 3, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- March 19, 2026 --

Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- March 12, 2026 --

Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19 Globe Newswire 8:00 AM

-- March 6, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- February 6, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- January 6, 2026 --

Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes